Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-008614

CHAIRMAN & CEO gave up 2,004 shares (to pay taxes)

  • CHAIRMAN & CEO acquired 6,569 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Sanj K CHAIRMAN & CEO 2025-03-16 Option exercise +6,569 86,120 D
Patel Sanj K CHAIRMAN & CEO 2025-03-16 Shares withheld for taxes −2,004 $22.61 $45,310 84,116 D
Derivatives
Patel Sanj K CHAIRMAN & CEO 2025-03-16 Option exercise · Restricted Share Unit −6,569 0 D
Loading xslF345X05/form4-03192025_090332.xml…